Results 331 to 340 of about 106,721 (360)
Some of the next articles are maybe not open access.
Localized Sclerosing Cholangitis?
Endoscopy, 1985Primary sclerosing cholangitis presenting as a localized stricture affecting a segment of the extrahepatic biliary tree is seldom found. This article describes the case of a 56-year-old male admitted with obstructive jaundice, in whom endoscopic retrograde cholangiography showed a localized and smooth stricture at the common hepatic duct, initially ...
J, Panés +4 more
openaire +2 more sources
Epidemiological features of immunoglobulin G4‐related sclerosing cholangitis in Japan
Journal of hepato-biliary-pancreatic sciences, 2020Epidemiological data on immunoglobulin G4‐related sclerosing cholangitis (IgG4‐SC) are scarce.
A. Tanaka +9 more
semanticscholar +1 more source
EASL Clinical Practice Guidelines on Sclerosing Cholangitis.
Journal of Hepatology, 2022O. Chazouilleres +7 more
semanticscholar +1 more source
Primary sclerosing cholangitis
Clinics in Liver Disease, 2004Primary sclerosing cholangitis is a cholestatic liver disease strongly associated with IBD. Considerable advances in the understanding of its pathogenesis have been made. The idea of autoimmunity affecting genetically susceptible individuals is largely accepted; however, much remains to be explained about the origin of this disease.
Flavia D, Mendes, Keith D, Lindor
openaire +2 more sources
Hepatology Research, 2019
Autoimmune liver diseases (AILD) including autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC) impose a significant burden on public health, and it is important to estimate their prevalence.
A. Tanaka +5 more
semanticscholar +1 more source
Autoimmune liver diseases (AILD) including autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC) impose a significant burden on public health, and it is important to estimate their prevalence.
A. Tanaka +5 more
semanticscholar +1 more source
Primary Sclerosing Cholangitis
Surgical Clinics of North America, 1981In spite of an improved understanding of the etiology of primary sclerosing cholangitis, which supports the use of immunosuppressive therapy with steroids and azathioprine, these pharmacologic manipulations have not altered the ultimate outcome of the disease. Drainage remains the most accepted mode of therapy when possible.
L F, Williams, D J, Schoetz
openaire +2 more sources
Primary Sclerosing Cholangitis
New England Journal of Medicine, 1995Y M, Lee, M M, Kaplan
openaire +2 more sources

